2018 International AF Symposium: My First Report
Held Jan. 11-13, 2018 in Orlando, FL, the annual International AF Symposium is an intensive and highly focused three-day scientific forum which brings together the world’s leading medical scientists, researchers, cardiologists and electrophysiologists to share the most recent advances in the treatment of atrial fibrillation.
The 45 distinguished faculty were leaders in the Atrial Fibrillation field from around the world (the U.S., England, Canada, France, Italy, Germany, Switzerland, Ireland, The Netherlands, Russia, Taiwan, South Korea, the Czech Republic, and two members of the U.S. FDA [Food and Drug Administration].

I made it to every presentation despite being sick with some kind of a virus I caught on the plane to Orlando. I was running on fumes.
Hot Topics
KISS OF DEATH FOR FIRM?
In a late-breaking presentation, the interim results of REAFFIRM trial were presented by Dr. John Hummel from the Ohio State University Wexner Medical Center. The success rate for PVI plus FIRM was not significantly different (78%) for patients receiving only a standard PVI (70%).
Barring further research, this may mean the end of the FIRM system as an effective player in A-Fib ablation. See my upcoming report for more.
FOCUS ON LEFT ATRIAL APPENDAGE
Like last year, there was great interest in and examination of the importance of the Left Atrial Appendage (LAA). Four of the six live case presentations dealt with the LAA. Ten of the more than 62 presentations focused on the LAA.
…To continue reading… Go to My Overview of the 2018 International AF Symposium->
Dr. Ruskin
“Steve Ryan’s summaries of the A-Fib Symposium are terrific. Steve has the ability to synthesize and communicate accurately in clear and simple terms the essence of complex subjects. This is an exceptional skill and a great service to patients with atrial fibrillation.” — Dr. Jeremy Ruskin of Mass. General Hospital and Harvard Medical School






